抗MDA5抗体相关间质性肺病的发病季节与居住地聚集性
提示环境因素可能影响该亚型发病。
要点
- 抗MDA5阳性者居住地更靠近水域,尤其是淡水。
- 抗ARS阳性及抗体阴性者未发现季节关系。
研究设计与样本
- 多中心队列中,365例用于季节分析、481例用于地理分析,按抗MDA5、抗ARS及双阴性分三组。
- 季节分析采用Rayleigh检验,居住地距最近水域距离用Google Map测量并以精确Wilcoxon秩和检验比较。
主要发现
- 抗MDA5阳性患者发病时居住地显著更靠近水域,尤其淡水,与抗ARS阳性者比较p=0.003,与双阴性者比较p=0.006。
临床怎么用
- 对疑似抗MDA5相关ILD患者,可关注发病季节及居住地水域暴露史作为环境线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether the onset of polymyositis (PM)/dermatomyositis (DM)-associated interstitial lung disease (ILD) is influenced by season and residence in the context of myositis-specific autoantibodies. METHODS: For patients with PM/DM-associated ILD enrolled in a multicentre cohort, 365 and 481 patients were eligible for seasonal and geographical analysis, respectively, based on the availability of reliable clinical information. The patients were divided into three groups: (1) anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive patients, (2) anti-aminoacyl tRNA synthetase (anti-ARS) antibody-positive patients and (3) patients negative for those antibodies. Seasonality was assessed by the Rayleigh test. Distance from residence to the nearest waterfront was measured on Google Map and was compared between groups by the exact Wilcoxon rank-sum test. RESULTS: In anti-MDA5-positive patients, the disease developed more frequently in October-March (p=0.03), whereas a seasonal relationship was not found in the remaining two patient groups. Residence at disease onset in anti-MDA5-positive patients was significantly closer to the waterfront, especially to freshwater, compared with that in anti-ARS-positive or anti-MDA5-/ARS-negative patients (p=0.003 and 0.006, respectively). CONCLUSIONS: Anti-MDA5-associated ILD occurred predominantly from October to March in individuals residing near freshwater, suggesting an environmental influence on the onset of this disease subset.
引用
- Nishina N, Sato S, Masui K, et al. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. 2020. PMID: 32506053. doi:10.1136/rmdopen-2020-001202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。